PMOS: New global name for PCOS to spotlight systemic health
TL;DR
After a 14-year global consensus involving 56 organizations and about 22,000 participants, Polycystic Ovary Syndrome is officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) to reflect its systemic hormonal and metabolic nature. The rename aims to reduce stigma, improve diagnosis, and align clinical practice over the next three years, with around 1 in 8 women affected by PMOS. The effort was led by researchers including Prof. Helena Teede and advocacy by Lorna Berry, highlighting the shift away from a cyst-centric view to a broader endocrine health perspective.
Topics:top-newshealth-and-medicine#endocrinology#health-and-medicine#pcos#pmos#renaming#womens-health
- PCOS, affecting 1 in 8 women worldwide, now called PMOS Ground News
- P.C.O.S. Has a New Name. Doctors Hope It Will Improve Care for Millions. The New York Times
- Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide Endocrine Society
- ‘Unprecedented’ global effort gives new name to polycystic ovary syndrome – and new hope to millions of women The Guardian
- PCOS Is Officially Renamed, After Decades of Misinformation ScienceAlert
Want the full story? Read the original reporting
Read on Ground News